Elicio Therapeutics Inc —— 季度财务数据 (NASDAQ:ELTX) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -8.74 M-10.12 M-8.95 M-11.09 M-6.8 M -36.95 M 投资活动产生的现金 -45 K000-16 K -16 K 融资活动产生的现金 227 K10.33 M11.93 M9.57 M4.86 M 36.7 M 自由现金流 -8.79 M-10.12 M-8.95 M-11.09 M-6.81 M -36.97 M

新闻

Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?

Elicio Therapeutics启动1亿美元市场发售股票计划

H.C. Wainwright上调Elicio Therapeutics目标价至17美元

H.C. Wainwright raises Elicio Therapeutics price target to $17

Rodman & Renshaw首次覆盖Elicio Therapeutics股票,给予买入评级

Rodman & Renshaw initiates Elicio Therapeutics stock with buy rating

Is Quest Diagnostics (DGX) Stock Outpacing Its Medical Peers This Year?

Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why

Elicio reports antigen spreading in 87% of evaluated cancer patients

Elicio Therapeutics appoints Marc Wolfgang as chief technology officer

Elicio reports strong immune responses in phase 2 KRAS cancer vaccine trial

Elicio’s cancer therapy shows immune response across diverse HLA types